Dirk Hendriks

Dirk Hendriks is the founder of HistoGeneX N.V., where the focus has been on the development of predictive biomarkers in oncology since 2001. Additionally, Dirk Hendriks has served as a professor and head of the Laboratory of Medical Biochemistry in the Department of Pharmaceutical Sciences at the University of Antwerp since 1985. Dirk Hendriks holds a PhD in clinical pathology with a specialization in fibrinolysis, as well as a PharmD and a second PhD in Pharmaceutical Sciences and Clinical Pathology, all obtained from the University of Antwerp.